Granted projects

For CerTest Biotec R&D is part of its essence. In addition to carrying out research with its own funds, the company CerTest Biotec has been the beneficiary of various competitive grants and has been awarded innovative public procurement tenders such as those detailed below.

Last project

CDTI- Science and Innovation Missions 2021: Center for Technological and Industrial Development (CDTI)

  • Project title: Development of thermostable vaccines based on mRNA against the Delta variant of SARS-CoV-2.
  • Type of project: Pre-competitive research project in cooperation

  • Execution time: 15/09/2021 – 31/12/2023

  • Total project budget: 2.831.200,57 €

  • Budget for CerTest: 827.348,25 €

The  objective of this project is the development of a vaccine against the Delta variant of SARS-CoV-2 based on messenger RNA (mRNA) technology that is effective in preventing the disease, and with greater stability in terms of its preservation than current vaccines. The project will facilitate the design and rapid development of other vaccines against various infectious diseases (including new pathogenic variants of coronavirus) and also for cancer immunotherapy.

Learn more

Granted projects list

Newsletter

Receive all the news of Certest Biotec in your email

SUBSCRIPTION